Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Management of Urinary Retention in Patients with Enlarged Prostate

Immediate Management

  • The American Urological Association recommends immediate bladder decompression via urethral catheterization to relieve acute urinary retention and prevent bladder damage in patients with enlarged prostates 1
  • Using silver alloy-coated urinary catheters can reduce the risk of urinary tract infection during catheterization in patients with urinary retention 1
  • Suprapubic catheterization is the preferred option for chronic indwelling catheter use due to reduced risk of urethral trauma, and should be considered if urethral catheterization is difficult or unsuccessful 2, 3
  • Ultrasound guidance during suprapubic tube placement can help mitigate risks such as bowel perforation or vascular injury in patients requiring suprapubic catheterization 3

Medical Management After Catheterization

  • Administering a non-titratable alpha blocker prior to attempting catheter removal can improve chances of successful voiding trial in patients with enlarged prostates 1
  • The European Association of Urology recommends considering 5-alpha reductase inhibitors like finasteride for patients with enlarged prostates (>30cc) to reduce the risk of future episodes of retention 1

Surgical Management Options

  • Surgery is recommended for patients with refractory retention who have failed at least one attempt at catheter removal, according to the American Urological Association 1
  • Transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for BPH-related urinary retention, as stated by the European Association of Urology 1
  • Other surgical options include holmium laser enucleation of the prostate or photovaporization of the prostate, which have shown significant improvements in maximum urinary flow rate, post-void residual volume, and reduction in detrusor overactivity 3

Follow-Up and Monitoring

  • Remove indwelling catheters as soon as medically possible, ideally within 24-48 hours, to minimize infection risk in patients with urinary retention 1
  • Patients who successfully void after catheter removal should be informed that they remain at increased risk for recurrent urinary retention, as advised by the American Urological Association 1

Important Considerations and Pitfalls

  • Avoid delaying surgical intervention in patients with refractory retention, as this can lead to bladder decompensation and chronic retention, according to the European Association of Urology 1
  • Patients with chronic indwelling urethral catheters are at risk for urethral trauma, including erosion and, in severe cases, urethral loss, significant urinary incontinence, and the need for reconstructive surgery 3
  • When considering suprapubic catheterization, be aware of potential complications including granulation tissue formation, bleeding, catheter site erosion, and loss of access during catheter changes 3
  • For patients with BPH undergoing surgical interventions, counsel them about the possibility of experiencing de novo or worsening overactive bladder symptoms after the procedure, as recommended by the American Urological Association 3